CAMSAP2

Across TCGA pan-cancer cohorts, CAMSAP2 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CAMSAP2 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CAMSAP2 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CAMSAP2 expression acts as an unfavorable survival marker, although some lineages such as GBM and HNSC show a favorable association.

CCRCC, LSCC, and GBM are the cancer types where CAMSAP2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	II,III,IV	0.717	0.897	.011	15	view →
LSCC	DFS	Median	All	0.600	0.791	.016	9	view →
GBM	DFS	Quartile	All	0.875	0.658	.015	6	view →
HNSC	DFS	Quartile	II,III,IV	1.000	0.901	.021	3	view →
PDAC	OS	Quartile	II,III,IV	0.357	0.565	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CAMSAP2–CCRCC (OS)

Open the CCRCC breakdown →